The BMP receptor inhibitors JL5 and DMH2 have been shown to cause a greater decrease in the expression of the BMP signaling proteins ID1, XIAP, and TAK1, and induce more cell death of lung cancer cell lines than the BMP inhibitors DMH1 and LDN [20]. This evidence concerns the gene XIAP and lung carcinoma.